Status:
COMPLETED
Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
Lead Sponsor:
University of Western Ontario, Canada
Conditions:
Neuroendocrine Carcinoma (Carcinoid)
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this study is to compare several methods for measurement of Chromogranin A in their ability to serve as a marker for disease activity in patients with neuroendocrine tumors. Further, in a...
Detailed Description
Patient group: patients with neuroendocrine tumors (active or inactive) Healthy volunteers
Eligibility Criteria
Inclusion
- Patients:
- having neuro-endocrine disease
Exclusion
- age below 18 or above 70 years
- prostate cancer
- kidney failure (estimated GF \< 30 mL/Min)
- heart failure
- chronic atrophic gastritis
- pregnancy
- Healthy subjects:
- Inclusion Criteria:
- healthy
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01216267
Start Date
June 1 2010
End Date
January 1 2012
Last Update
January 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Center and St. Joseph's Health Care
London, Ontario, Canada, N6A 4V2